
Leuprolide Stabilizes Alzheimer’s Memory Loss
CLINICAL TRIAL: In Alzheimer’s trials, Leuprolide (an FDA approved cancer drug) stabilized memory loss for a full year. This is the first time any therapy

CLINICAL TRIAL: In Alzheimer’s trials, Leuprolide (an FDA approved cancer drug) stabilized memory loss for a full year. This is the first time any therapy

CLINICAL TRIALS VIDEO: 2015 has seen a big jump in the number of people volunteering for dementia research. Find out more about this hopeful surge

CNN VIDEO + INFO: Amyloid plaque buildup on the brain can begin decades before it actually triggers Alzheimer’s. See how The A4 Trial hopes to

In Phase 2 trials, Anavex performed as much as 4 times better than Aricept®, today’s most popular Alzheimer’s medication. The pill achieved cognitive and functional

CBS VIDEO + ARTICLE: Excitement and Hope are 2 words not often heard in Alzheimer’s clinical trials, but new results for solanezumab are generating quite

150 Alzheimer’s clinical trials are looking for volunteers in the USA. They are trying out the newest drugs and therapies on 70,000 people with various

VIDEO: “For the first time I think we have a chance to really change the course of Alzheimer’s disease,” says Dr. Reisa Sperling. She’s leading

VIDEO & ARTICLE: CNBC’s Meg Tirrell reports on Biogen’s experimental drug for Alzheimer’s and how the company appears to have exceeded expectations.

VIDEOS + ARTICLE: Renowned model, actress and restauranteur B. Smith and her husband, Dan Gasby, talk about life with Alzheimer’s. See her new video to

VIDEO + ARTICLE: The A4 Study is a cutting-edge trial aimed at preventing Alzheimer’s. The clinical trial is testing healthy adults who are at risk

The protein BDNF builds synapses in the human brain, nurturing brain cells and fighting off dementia. While there is no artificial way of boosting it, social and cognitive activity can.

Memory failing? New research shows you may need help, but not for dementia. Memory slips, stress and fatigue are growing in people with healthy memory.

People may not have easy access to sophisticated, expensive dementia tests. A simple test from Einstein Medicine uses a stopwatch and a few questions to determine one’s risk of dementia. The potential payoff could be tremendous for individuals, their families and society.

Dr. Richard Taylor has Alzheimer’s and the right attitude!

Swedish researchers find that cholinesterase inhibitors provide cognitive benefits and reduce mortality for up to five years after an Alzheimer’s diagnosis. One medication significantly reduced the risk of developing severe dementia.

Researchers find optimistic people contribute to the health of their partners, staving off risk factors leading to Alzheimer’s disease, other dementias and cognitive decline as they grow old together.

Bringing art and creativity into elder care settings helps families reconnect with loved ones who have dementia. In this moving talk, Anne Bastings shares how.
No spam, only news and updates.


